Nasopharyngeal Neoplasms - 21 Studies Found Completed : Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy : Nasopharyngeal Neoplasms : 2008-02-25 : Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen Completed : Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) : Nasopharyngeal Neoplasms : 2008-09-04 : Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni Recruiting : Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122) : : 2024-11-23 Completed : The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT : Nasopharyngeal Neoplasms : 2013-02-21 : Drug: Cisplatin induction: Cis Completed : Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer : Nasopharyngeal Neoplasms : 2007-12-18 : Procedure: Conventional Radiotherapy Proce Completed : Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2007-02-16 : Drug: Gemcitabine 1000mg/m Completed : Taxotere + Cisplatin in Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2007-02-16 : Drug: Docetaxel 75 mg/m² Completed : Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2006-08-11 : Drug: Oxaliplatin 130mg/m² infusion day 1, repeat every 21 days Active, not recruiting : Intensity Modulated Radiation Therapy for Head and Neck Cancer : Nasopharyngeal Neoplasms : 2005-09-12 : Procedure: intensity modulated radiation therapy Completed : Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function : Nasopharyngeal Neoplasms : 2005-07-22 : Procedure: Intensity-modulated radiation therapy Next >>>
